SCHEMBL19456380

SCHEMBL19456380

CNC(=O)c1cc(C=O)cc2c1OC(COSC)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19456253 0.84 BRD4 (0.32) —
SCHEMBL19456305 0.84 BRD4 (0.32) —
SCHEMBL19456300 0.83 BRD4 (0.37) —
SCHEMBL19456110 0.78 PARP1 (0.46) —
SCHEMBL20887077 0.70 PARP1 (0.42) —
SCHEMBL21649797 0.68 BRD4 (0.43) —
SCHEMBL19456132 0.68 RXFP1 (0.33) —
SCHEMBL19456080 0.67 RXFP1 (0.38) —
SCHEMBL19456190 0.67 BRD4 (0.49) —
SCHEMBL19456159 0.67 BRD4 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440075-B1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2020-01-29 — — EP disclosed
WO-2017174620-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-10-12 — — WO disclosed
Send feedback